The Food and Drug Administration is currently accepting public comments on the agency’s proposed plans to implement a law that will restrict compounding of human drug products.

A statement issued by the FDA provides links to two draft guidances that describe how the agency “would implement provisions of federal law that restrict compounding human drug products that are essentially copies of commercially available or approved drug products.” One draft guidance and the legal restrictions referenced therein are relevant to physicians and pharmacists, as well as state-licensed pharmacies or federal facilities that compound drugs, according to the FDA. The other guidance applies to outsourcing facilities.

Although compounded drug products, such as a medication made without a dye for a patient allergic to that dye, or a medication made into liquid form for a patient who cannot swallow a pill, “may benefit certain patients whose medical needs cannot be met by a commercially available or an FDA-approved drug product,” the FDA statement said. “Taking compounded drug products that are essentially copies of a commercially available or approved drug needlessly exposes patients to drug products that FDA has not evaluated for safety, effectiveness, and quality. In addition, the compounded drugs may not have been produced according to appropriate quality standards. Such compounding would also undermine the new drug approval and over-the-counter drug monograph systems in the United States.”

The statement refers to serious adverse events, including infections and deaths that have resulted from “poor-quality” compounded drugs.

Written or electronic comments can be submitted until Oct. 11, and information on submitting comments is available at regulations.gov .

emechcatie@frontlinemedcom.com

Ads

You May Also Like

Stem cells may provide long-term relief from Crohn’s fistula

FROM STEM CELLS TRANSLATIONAL MEDICINE Three-quarters of Crohn’s fistula patients who were treated with ...

Steroid use in adolescents

Anabolic androgenic steroid (AAS) use in athletes is not a new topic. In fact, ...

How to get the most out of methotrexate for psoriasis

EXPERT ANALYSIS FROM THE SDEF HAWAII DERMATOLOGY SEMINAR WAILEA, HAWAII (FRONTLINE MEDICAL NEWS) – ...